Literature DB >> 25460581

Analysis of the absorption kinetics of macromolecules following intradermal and subcutaneous administration.

Mikolaj Milewski1, Kimberly Manser2, Becky P Nissley2, Amitava Mitra2.   

Abstract

Recent years have witnessed rapid growth in the area of microneedle-assisted intradermal drug delivery. Several publications involving in vivo studies in humans and minipigs have demonstrated distinct change in pharmacokinetics of peptides and proteins following intradermal (ID) administration as compared to subcutaneous (SC) injections. Specifically, ID administration produced a "left-shift" in pharmacokinetic profiles i.e. shorter time to achieve maximum plasma concentrations (shorter Tmax), and often higher maximum plasma concentrations (higher Cmax), as compared to the SC route. In the present work differences in the kinetics of drug absorption after ID and SC administration were explored for eight peptides and proteins with the focus on obtaining quantitative information about the absorption process and identifying similarities and differences in the absorption behavior across compounds. We confirmed that systemic uptake, as judged by apparent absorption rate constants, was 2- to 20-fold higher from the dermis as compared to the subcutis. Additionally, shapes of time-resolved absorption rate profiles demonstrated notable differences in absorption kinetics between ID and SC routes. For both administration routes evaluated herein there was a general trend of small macromolecules absorbing at higher rates as compared to the large macromolecules.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Absorption; Intradermal; Microneedles; Peptide; Protein; Subcutaneous

Mesh:

Substances:

Year:  2014        PMID: 25460581     DOI: 10.1016/j.ejpb.2014.11.013

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  4 in total

1.  Evaluating the Impact of Human Factors and Pen Needle Design on Insulin Pen Injection.

Authors:  Christopher Rini; Bruce C Roberts; Didier Morel; Rick Klug; Benjamin Selvage; Ronald J Pettis
Journal:  J Diabetes Sci Technol       Date:  2019-03-17

2.  Intradermal insulin infusion achieves faster insulin action than subcutaneous infusion for 3-day wear.

Authors:  Christopher James Rini; Elaine McVey; Diane Sutter; Stephen Keith; Heinz-Joerg Kurth; Leszek Nosek; Christoph Kapitza; Kerstin Rebrin; Laurence Hirsch; Ronald J Pettis
Journal:  Drug Deliv Transl Res       Date:  2015-08       Impact factor: 4.617

3.  Epitope-Specific Immunotherapy Targeting CD4-Positive T Cells in Celiac Disease: Safety, Pharmacokinetics, and Effects on Intestinal Histology and Plasma Cytokines with Escalating Dose Regimens of Nexvax2 in a Randomized, Double-Blind, Placebo-Controlled Phase 1 Study.

Authors:  A James M Daveson; Hooi C Ee; Jane M Andrews; Timothy King; Kaela E Goldstein; John L Dzuris; James A MacDougall; Leslie J Williams; Anita Treohan; Michael P Cooreman; Robert P Anderson
Journal:  EBioMedicine       Date:  2017-11-22       Impact factor: 8.143

4.  Transdermal Drug Delivery in the Pig Skin.

Authors:  Ignacio Ordiz; José A Vega; Raquel Martín-Sanz; Olivia García-Suárez; Miguel E Del Valle; Jorge Feito
Journal:  Pharmaceutics       Date:  2021-11-26       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.